Insider Transactions in Q4 2022 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Emil D Kakkis President & CEO |
SELL
Open market or private sale
|
Direct |
19,582
-3.49%
|
$881,190
$45.57 P/Share
|
|
Dec 21
2022
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,031
-11.14%
|
$87,333
$43.96 P/Share
|
|
Oct 14
2022
|
Mardi Dier CFO & Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,629
-2.38%
|
$65,160
$40.16 P/Share
|
|
Oct 12
2022
|
Mardi Dier CFO & Executive Vice President |
SELL
Open market or private sale
|
Direct |
3,484
-4.85%
|
$132,392
$38.22 P/Share
|